Article

Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis

2024-08-13

Abstract excerpt

<h4>Structured Summary</h4> <h4>Background</h4> With increasing recognition of the value of incorporating prognostic markers into amyotrophic lateral sclerosis (ALS) trial design and analysis plans, there is a pressing need to understand which among the prevailing clinical and biochemical markers have real value, and how they can be optimally used. <h4>Methods</h4> A subset of patients with ALS recruited through t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd8a8078-e888-572e-8eec-d9d1f34508c0
DOI: 10.1101/2024.08.12.24311876

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and AnalysisDOI 10.1101/2024.08.12.24311876Read

Population-based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral SclerosisSemantic proximity Read

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.Semantic proximity Read

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read

Real-World Serum Neurofilament Light Chain and GFAP in Amyotrophic Lateral Sclerosis on a Commercial ECLIA PlatformSemantic proximity Read

Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosisSemantic proximity Read

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosisSemantic proximity Read

Presymptomatic amyotrophic lateral sclerosis: from characterization to preventionSemantic proximity Read

Serum neurofilament light as a biomarker for prognosis in patients with newly diagnosed Parkinson’s diseaseSemantic proximity Read

Troponin T and Neurofilament Light Chain Levels as Complementary Biomarkers of Disease Accumulation and Aggressiveness in Amyotrophic Lateral SclerosisSemantic proximity Read

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.Semantic proximity Read

Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK BiobankSemantic proximity Read